EMILY MILBURN: Open Payments
NPI 1669124459 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 28 payments from 10 companies in 2025. Trend: 2023 $1,401 · 2024 $1,085 · 2025 $572
Food & beverage: $558Education: $15
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $158 |
| Lilly USA, LLC | 5 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75 |
| Dexcom, Inc. | 2 | $49 |
| Exact Sciences Corporation | 3 | $48 |
| Novo Nordisk Inc | 3 | $44 |
| ABBVIE INC. | 2 | $42 |
| ANI Pharmaceuticals, Inc. | 2 | $35 |
| Boston Scientific Corporation | 1 | $18 |
| PFIZER INC. | 1 | $14 |
Products named: AIRSUPRA, MOUNJARO, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit, VRAYLAR, PURIFIED CORTROPHIN GEL, JARDIANCE, FARXIGA.
Industry payments across MO — which companies pay providers there.
